Susan Lehman
Family Medicine · Traverse City, MINPI 1134128671
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $554 and has fallen 80.8% since, to $106 in 2022.
Across 96 payments — averaging $12.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$237
- AstraZeneca$122
- AbbVie$83
- Amgen$73
- Merck$70
- Novartis$65
- plus $574 from 20 others
What the payments were for
- Food & beverage$1,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 30 | $237 |
| AstraZeneca | 8 | $122 |
| AbbVie(2 entities) | 4 | $83 |
| Amgen | 5 | $73 |
| Merck | 5 | $70 |
| Novartis | 4 | $65 |
| Johnson & Johnson | 5 | $59 |
| Sanofi Pasteur Inc. | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Sunovion Pharmaceuticals Inc. | 6 | $48 |
| Boehringer Ingelheim | 2 | $42 |
| Dexcom, Inc. | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Ironshore Pharmaceuticals Inc. | 2 | $27 |
| Novo Nordisk | 2 | $25 |
| Neos Therapeutics, LP | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
| Pfizer | 1 | $17 |
| Bayer | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| UCB, Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Biogen | 1 | $13 |
How this compares
$1,225 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Traverse City
- Rafay BaigTraverse City$48K
- Kathryn ShafferTraverse City$20K
- Michael CarrollTraverse City$18K
- David BestTraverse City$16K
- Nathan SailorTraverse City$16K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.